145 related articles for article (PubMed ID: 1823815)
1. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Troncone L; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):186-90. PubMed ID: 1823815
[TBL] [Abstract][Full Text] [Related]
2. Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines.
Iavarone A; Lasorella A; Servidei T; Riccardi R; Mastrangelo R
Cancer Res; 1993 Jan; 53(2):304-9. PubMed ID: 8417824
[TBL] [Abstract][Full Text] [Related]
3. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
Smets LA; Loesberg C; Janssen M; Metwally EA; Huiskamp R
Cancer Res; 1989 Jun; 49(11):2941-4. PubMed ID: 2720653
[TBL] [Abstract][Full Text] [Related]
4. In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells.
Montaldo PG; Carbone R; Lanciotti M; Ponzoni M; Cornaglia-Ferraris P
J Nucl Biol Med (1991); 1991; 35(4):195-8. PubMed ID: 1823817
[TBL] [Abstract][Full Text] [Related]
5. HBO and the uptake and retention of [125I] MIBG in human platelets and two neuroendocrine cell lines.
Tytgat GA; Cornelissen J; Van den Brug M; Van Kuilenburg AB; Voute PA; Van der Kleij AJ; Van Gennip AH
Anticancer Res; 1997; 17(2A):1209-12. PubMed ID: 9137473
[TBL] [Abstract][Full Text] [Related]
6. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
Buck J; Bruchelt G; Girgert R; Treuner J; Niethammer D
Cancer Res; 1985 Dec; 45(12 Pt 1):6366-70. PubMed ID: 3864530
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma-induced differentiation of human neuroblastoma cells increases cellular uptake and halflife of metaiodobenzylguanidine.
Montaldo PG; Carbone R; Cornaglia Ferraris P; Ponzoni M
Cytotechnology; 1993; 11 Suppl 1():S140-3. PubMed ID: 7763744
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
Bruchelt G; Girgert R; Buck J; Wolburg H; Niethammer D; Treuner J
Cancer Res; 1988 Jun; 48(11):2993-7. PubMed ID: 3365688
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
Weber W; Weber J; Senekowitsch-Schmidtke R
Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
[TBL] [Abstract][Full Text] [Related]
10. SIMS microscopy imaging of the intratumor biodistribution of metaiodobenzylguanidine in the human SK-N-SH neuroblastoma cell line xenografted into nude mice.
Clerc J; Halpern S; Fourré C; Omri F; Briançon C; Jeusset J; Fragu P
J Nucl Med; 1993 Sep; 34(9):1565-70. PubMed ID: 8355077
[TBL] [Abstract][Full Text] [Related]
11. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells.
Montaldo PG; Raffaghello L; Guarnaccia F; Pistoia V; Garaventa A; Ponzoni M
Int J Cancer; 1996 Jul; 67(1):95-100. PubMed ID: 8690531
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
Montaldo PG; Lanciotti M; Casalaro A; Cornaglia-Ferraris P; Ponzoni M
Cancer Res; 1991 Aug; 51(16):4342-6. PubMed ID: 1868458
[TBL] [Abstract][Full Text] [Related]
14. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
Smets LA; Rutgers M
J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
[No Abstract] [Full Text] [Related]
15. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
Strickland DK; Vaidyanathan G; Zalutsky MR
Cancer Res; 1994 Oct; 54(20):5414-9. PubMed ID: 7923174
[TBL] [Abstract][Full Text] [Related]
16. Release mechanisms of [125I]meta-iodobenzylguanidine in neuroblastoma cells: evidence of a carrier-mediated efflux.
Servidei T; Iavarone A; Lasorella A; Mastrangelo S; Riccardi R
Eur J Cancer; 1995; 31A(4):591-5. PubMed ID: 7576975
[TBL] [Abstract][Full Text] [Related]
17. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
19. Specific uptake of 125-I-metaiodobenzylguanidine in human neuroblastoma cell lines is associated with the neuroblastic cell type.
Iavarone A; Servidei T; Riccardi R; Lasorella A; Mastrangelo R
Prog Clin Biol Res; 1991; 366():447-54. PubMed ID: 2068158
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
Gaze MN; Hamilton TG; Mairs RJ
Br J Radiol; 1994 Jun; 67(798):573-8. PubMed ID: 8032811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
